Does antipsychotic use mediate the effect of psychiatric disorders on COVID-19? - Authors' reply
- PMID: 33665643
- PMCID: PMC7906648
- DOI: 10.1016/S2666-7568(21)00007-6
Does antipsychotic use mediate the effect of psychiatric disorders on COVID-19? - Authors' reply
Comment on
-
Pre-pandemic psychiatric disorders and risk of COVID-19: a UK Biobank cohort analysis.Lancet Healthy Longev. 2020 Nov;1(2):e69-e79. doi: 10.1016/S2666-7568(20)30013-1. Epub 2020 Oct 26. Lancet Healthy Longev. 2020. PMID: 33521769 Free PMC article.
-
Antipsychotic use and psychiatric disorders in COVID-19.Lancet Healthy Longev. 2021 Feb;2(2):e64. doi: 10.1016/S2666-7568(20)30063-5. Epub 2021 Feb 3. Lancet Healthy Longev. 2021. PMID: 33665642 Free PMC article. No abstract available.
References
-
- Dzahini O, Singh N, Taylor D, Haddad PM. Antipsychotic drug use and pneumonia: systematic review and meta-analysis. J Psychopharmacol. 2018;32:1167–1181. - PubMed
-
- Almirall J, Serra-Prat M, Baron F, Palomera E, Bolíbar I. The use of benzodiazepines could be a protective factor for community-acquired pneumonia (CAP) in ≤60-year-old subjects. Thorax. 2013;68:964–965. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
